ArticleBreast cancer (Dove Medical Press)2025

Non-Luminal Disease Score for Everolimus in Patients with Hormone Receptor‑positive and Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: A Multicenter and Retrospective Study.

Yujing Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.